Dr. Shenoy is an infectious diseases physician at Massachusetts General Hospital (MGH), where she is Associate Chief of the Infection Control Unit. She is an Associate Professor of Medicine at Harvard Medical School. Her research has evaluated the clinical, operational and economic impact of infection control strategies for multi-drug resistant pathogens and prevention of hospital acquired infections through clinical studies and mathematical modeling, use of electronic health records for surveillance, and applied machine-learning techniques to create risk prediction models for infectious diseases. She is known for her teaching and publications on detection and prevention of nosocomial infections and interventions, evaluation and management of healthcare personnel (HCP) exposure to infectious agents, as well as pre- and post-exposure prophylaxis of HCP. During the COVID-19 pandemic she has served as the principal subject matter expert on infection prevention and control at MGH, and advised the Mass General Brigham response.

Dr. Shenoy is the Principal Investigator on a CDC-funded National Infection Prevention Strengthening grant focused on HCP and patient safety, and is the Medical Director of the Regional Emerging Special Pathogens Treatment Center at MGH, one of ten federally-funded centers with expertise in preparedness and response for emerging pathogens. In this role, she has responsibility for development and implementation of a comprehensive infection prevention program for the MGH Biocontainment Unit and Special Pathogens Program.

Dr. Shenoy is a Fellow in both the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). She has served on the Guidelines Committee of SHEA and currently a member of SHEA’s Public Policy and Government Affairs Committee and co-chair of the Sterilization and High-Level Disinfection guidelines committee. An active member of IDSA, she previously served on the IDSA Antimicrobial Resistance Committee.